chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Back Pain; Cannot walk; hurt him to the point where it felt like a shock was sent from the back to lower ankles; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles). At the time of the report, BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received first dose and in one week patient experienced back pain, cannot walk and stated it hurt him to the point where it felt like a shock was sent from the back to lower ankles ( like sciatic nerve) and patient thought is it Guillain barre syndrome?. The patient stated that he wanted to see the doctor in person, but the doctor could only see him over a video call. The patient shortly thereafter refused to provide additional details about an adverse event.  No concomitant medication was reported.  No treatment medication was reported.
Open sore on Left side forehead, later right side at nose, later left side chest, then, left lower back, and arm swollen, red, and itches.
30 seconds after receiving the vaccine, I experienced dizziness, and difficulty concentrating, which lasted 40 minutes.
doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. There was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. Date place in refrigerator was 03Nov2021. Patient did not experience temperature excursion and any adverse event   No treatment medication was provided by reporter.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 38-year-old male patient received BNT162b2 (BNT162B2), on 16Mar2021 as dose 1, single (Lot number: EN6208), in left arm and on 06Apr2021 as dose 2, single (Lot number: ER8737) at the age of 37 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Moderate asthma" (unspecified if ongoing); "Interchange of vaccine products" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11May2022, outcome "not recovered" and all described as "Pfizer / BioNTech: Dose Number: 1: 16Mar2021, Dose Number: 2: 06Apr2021; Plaxovid: Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: patient had no known allergies and it was unknown if received other medications in two weeks. Patient was treated with paxlovid for Covid-19. Treatment start date was 13Apr2022. Treatment stop date was 17Apr2022. Patient began testing positive again and experiencing moderate symptoms 5 days after taking last dose of Paxlovid.
Client states that while sitting in her 15 minute observation period after 1st dose she felt a deep pain in her posterior Left thigh. She did not alert the medical staff of her pain and attempted to walk away from the observation site but due to the pain was limping. She was approached by the paramedic and lead RN outside of the facility. Vitals were taken and 911 called who advised patient should go to hospital for immediate evaluation and care. Patient refused transport and left against medical attention stating she would go to the emergency room with her daughter.
Pain at site; Fatigue; Headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 05Feb2021 10:00 (Lot number: EN5318) at the age of 56 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose: Date: 15Jan2021, Time: 10AM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: PFIZER EL3248, ADVERSE EVENTS:, AE Term: Pain at site, Onset date: 15Jan2021, Onset time: 9 hours, Seriousness criteria: Not serious, AE Outcome: Recovered, If recovered or recovered with sequelae, Date of recovery: 17Jan2021, Treatment: Did the adverse event require the initiation of new medication/ other treatment/ procedure?: No), administration date: 15Jan2021, when the patient was 56 years old, for COVID-19 immunization, reaction(s): "Pain at site". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 06Feb2021, outcome "recovered" (07Feb2021), described as "Pain at site"; FATIGUE (non-serious) with onset 06Feb2021, outcome "recovered" (15Feb2021), described as "Fatigue"; HEADACHE (non-serious) with onset 06Feb2021, outcome "recovered" (15Feb2021), described as "Headache". Therapeutic measures were not taken as a result of vaccination site pain, fatigue, headache.  Additional information: patient had Pain at site on 15Jan2021 9 hours, outcome was Recovered on 17Jan2021 and 08Feb2021. No treatment was received. Patient's Medical history including any illness at time of vaccination was reported as None. Family medical history and relevant tests were reported as none.   No follow-up attempts are needed. No further information is expected.
This happened the first dose, but the second has been far worse.  I've had a big pressure in my heart area, painful.  It feels like crushing pain.  I've been exhausted since and the pain remains.
upper abdominal pain; consistent vomiting and nausea; consistent vomiting and nausea; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Reporting System. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 (also reported as dose 2)  via an unspecified route of administration, administered in arm left on 09Mar2021 (at the age of 52-years; Lot Number: EN6206) (also reported as: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included alpha 1 antitrypsin deficiency and psoriasis. Concomitant medications included adalimumab (HUMIRA); escitalopram oxalate (LEXAPRO). The patient previously took cefalexin monohydrate (KEFLEX) and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. On 28Apr2021 08:00, the patient experienced sudden onset of upper abdominal pain followed by consistent vomiting and nausea for 5 days. The second episode with exact same symptoms occurred approximately 2 months after the vaccine was administered. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as the result of the events which included IV (unspecified, for clarification), Zofran, CT scan (unknown results). The outcome of the events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected.
Discharge Provider: MD  Primary Care Provider : DO    Admission Date: 8/24/2023 Discharge Date: 8/27/2023    CONDITION ON DISCHARGE: Stable and improved. Admitted as an Inpatient    HOSPITAL COURSE:   Came with fatigue and was found to have covid. He did not have any oxygen requirement, but improved with nebs and steroids.   He was found to have a troponin elevation to > 1000 and septal hypokinesis on echo. Cardiology recommended heparin drip for 48 hours, stabilization of covid, then transfer for Cardiac MRI.   He was transferred on Sunday for MRI Monday.   A further discharge summary will follow that admission.   He Has DM2, CKD, BPH, HTN ,HLD, chronic back and neck pain.
Single vulvar ulcer on L side. Appeared two days after second dose. Painful open sore. Lasted about one week before resolving on its own.
Red upraised circular lesion about 1in across. itchy. Area a little achy
1st dose on Aug2019, not yet received 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in August 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 09-AUG-2022 Reporter's Comments: The reporter was the patient.  The patient received first dose of Shingrix in August of 2019 and till the time of reporting he not yet received the second dose. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative. This physician reported same adverse event for different patients. This is first of the three reports. A patient (age, ethnicity and gender unknown) received PREVNAR 13 single dose, on an unspecified date. Relevant medical history and concomitant medications were unknown. It was reported that the patient experienced stinging during injecting PREVNAR 13. Therapeutic measures taken in response to the event were unknown. Clinical outcome of the event was unknown at time of this report. Follow-up (26Nov2013): Follow-up attempts completed. No further information expected.
12hr p/vax rash (small) appeared p/large whelps (2-3in diameter) over stomach, legs & back;no diff breathing wen to ER rt temp 102 11PM;given DPH & APAP;went back to ER ahd blood work, UA & CXR;pediatrician flet probably food allergy;
Severe leg pains/ symmetrical began day 5 after vaccine 1 Some arm pain but not so severe Symptoms have only improved slightly after 2 + months
Symptom onset within 15 minutes. At first, I was just a little dizzy. After about an hour or so, I started getting tingling sensations in my hands and feet. These sensation traveled in an ascending pattern up my legs and arms. I remember describing the feeling as 'heavy'. All of my limbs felt too difficult to lift. I had paraesthesia and decreased mobility. I received the Covid Vaccine at 11am and by 1pm, I was in the ER, unable to walk on my own. I was dizzy and unsteady on my feet and had an acute lack of coordination. I spent 1 day in the ICU, without mechanical ventilation, and was transferred to another hospital. I had to receive physical therapy both in the hospital and at home after I was discharged from the hospital. Since that time, I've developed issues with seasonal changes and allergies, to the point of needing an inhaler.
pt recv vax & 5min p/inj exp syncopal episode lasting approx 30sec to 1min;pt alert oriented x 3 immed p/episode-monitoring p/15min-stable condition allowed to return home;
Soreness and Pain on injection site, Chills / cold feeling all day 4/2/21,
Injection site arm got sore, red, swollen; he went to a walk-in immediate care facility where he was given a prescription for cephalexin 2 days after vaccination. Pt says feeling better when asked 7/7/11.
A patient was administered improperly stored PROQUAD; No adverse effects; A patient was administered improperly stored PROQUAD; This spontaneous report has been received from a nurse practitioner referring to a patient of unknown age and gender. Information regarding the patient's medical history, drug reaction or allergies, concurrent conditions and concomitant medications was not provided.   On 07-JUN-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # R011802 with expiration date of 21-OCT-2019, (strength, dose, route, frequency, and anatomical location were not provided) for prophylaxis.    The vaccine was exposed to temperature frames between 6°F to 14°F (13°F) for 7 hours, and between 15°F to 46°F (34°F) during 1 hour. No adverse effects were reported.
The patient  had pain in the right deltoid, numbness, decreased range of motion, nausea, and vomiting.
7 days after vaccination large, inflamed lump at injection site hit to touch   7 days after vaccination - started menestral cycle 7 days early while on birth control - menestral bleeding for10 days [normal cycle is 5 days]
This spontaneous prospective pregnancy report was received from a female patient of unknown age. On an unknown date in MAR-2013 (reported as end of March), the patient was vaccinated with first dose of GARDASIL, (lot number, expiry date and route was not reported) and found out that she was pregnant on the same day. Concomitant medications were not reported. The last menstrual period and estimated date of delivery were not reported. The patient stated that she had not had any side effects. Additional information is not expected.
"threw her into another hemiplegic migraine" lasted 10 or 11 days; whole body was shaking like her muscles were giving out; This spontaneous case was reported by a consumer and describes the occurrence of HEMIPLEGIC MIGRAINE ("threw her into another hemiplegic migraine" lasted 10 or 11 days) and TREMOR (whole body was shaking like her muscles were giving out) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 027A21A) for COVID-19 vaccination.     The patient's past medical history included Solar urticaria, Stomach ulcer with haemorrhage (bleeding stomach ulcers), MTHFR gene mutation (MTHFR(two strains)) and COVID-19 in December 2019. Concurrent medical conditions included Fibromyalgia, Atrial fibrillation, Heart disorder (heart issues), Type 2 diabetes mellitus, Migraine (all types of Migraines (all her life)), Trigeminal neuralgia (hypersensitive trigeminal neuralgia b1, b2, b3), Drug allergy (Haldol), Drug allergy (tramadol), Drug allergy (indomethacin), Latex allergy, Drug allergy (hydrocodone), Allergy to antibiotic (cephalexin), Drug allergy (promethazine), Drug allergy (venlafaxine), Caffeine allergy (coffee), Allergy to plants (lavender) and Allergy (sun). Concomitant products included LEVOTHYROXINE, SIMVASTATIN, VITAMIN D [VITAMIN D NOS], DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID]), PANTOPRAZOLE, DIGOXIN, METOPROLOL, METFORMIN, BUTALBITAL;CAFFEINE;CODEINE;PARACETAMOL, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), IBUPROFEN, PARACETAMOL (TYLENOL [PARACETAMOL]), MECLIZINE [MECLOZINE], POTASSIUM, FUROSEMIDE and GLYCERYL TRINITRATE (NITROSTAT) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced HEMIPLEGIC MIGRAINE ("threw her into another hemiplegic migraine" lasted 10 or 11 days) and TREMOR (whole body was shaking like her muscles were giving out). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. In April 2021, HEMIPLEGIC MIGRAINE ("threw her into another hemiplegic migraine" lasted 10 or 11 days) had resolved. At the time of the report, TREMOR (whole body was shaking like her muscles were giving out) outcome was unknown.            Patient is allergic to cillins. Patient stated that she was diagnosed with COVID-19 infection on Nov/Dec 2019 that lasted for 3 months. She reported that she was treated at the hospital and was given oxygen and stated she is still not fully recovered from the infection.   This case was linked to MOD-2021-422331, MOD-2021-422307 (Patient Link).
Started feeling mild to moderate numbness, tingling in feet, legs, and hands initially and spread to tongue and cheeks later.  Some hot flashes where cheeks would burn and it was soothing to run a fan in front of my face.  Felt weak and tired, legs felt heavy to walk.  Some pressure felt in the head and seeing sparks/lights occasionally mostly when blinking.  Some tightness of chest and shoulders on both sides that would come and go.   Mild to moderate lower back pain fairly consistent for 5+ weeks along with other events listed and then decreasing.  Only remaining symptoms at this time are some occasional mild burning sensation in my left foot and face and slight weekness/heaviness in the legs. I never had these symptoms before the shot.  I had COVID-19 a year ago end of October with mild symptoms, mostly fatigue and back ache for one week. I was tested and entered in the state database along with followup from them.  I have not received a medical exemption for boosters at this time but am extremely hesitant to risk getting them even at the expense of losing my job.
No adverse effect; the patient was administered a dose of improperly stored ROTATEQ; This spontaneous has been received from a medical assistant, concerning an approximately 9 week patient of unknown gender and ethnicity.    The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies and concomitant medication were not reported.  On 16-MAR-2019, the patient received a dose of improperly stored of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R002700 and expiration date 24-AUG-2019), taken orally as prophylaxis.  In addition, the vaccine was exposed to temperature: 1.2C for timeframe 30 minutes with previous excursion: -2.13C for 3 hours. The excursion call was made by a data logger. No adverse effects reported.  This is a one of the three patients.; Sender's Comments:  US-009507513-1905USA012681: US-009507513-1905USA012679:
This medical assistant was splashed in the eye with vax solution while she was administering the vax to the pt. It was noted that the pt jerked and some solution spilled off the vax and splashed her. She experienced burning eyes immediately which continued after flushing with tap water. She subsequently recovered form the episode. A female consumer was splashed during the same incident.
Patient received Moderna Covid-19 vaccine. She should have received Pfizer based on her age.
The day I got the vaccine immediately felt itchy all over, throat and eyes were itching. hard time breathing. Felt like I was swelling. I put on machine when I got home nd it help. I called my specialist he told me to take what I had already.
Sore arm & swollen lymph nodes in the lt arm that are tender upon palpation.
This spontaneous report was received from a physician via company representatives, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 19-JAN-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot No. K007263; expiration date 09-JUN-2016), "SDV;10 pack", (Route of administration and anatomical location were not reported). There was no concomitant therapy reported. On an unspecified dates, the RECOMBIVAX HB had two temperature excursions: one of 16 hours and 536 hours. The lowest recorded temperature was 33 F (0.555555556 Celsius) and the highest recorded temperature was 34 F (1.111111111 Celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
On 01/01/2001 the patient experienced 10 to 20 lesions. Subsequently, on 01/13/2001 the patient recovered from the lesions. No further information is available.
Swollen lymph nodes under right arm about the size of tennis ball on day two after injection has since spread into right breast and lymph nodes around right collar bone. Pain and fatigue.
No adverse reactions occurred. No allergic reaction. No injuection site pain. No illness post injection. Remained Afebrile. Patient's father is a professional firefighter. Patient's  mother is a registered nurse. Patient was watching closely for several weeks following injections. No adverse events occurred with either vaccine dose.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age. On unspecified dates, the patients were vaccinated with (Merck) VARIVAX which was exposed to unknown temperatures out of the recommended range for an unknown period of time (dose, route, lot number and expiration date unknown). No adverse effect had been reported. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information has been received from a physician and a licensed practical nurse (LPN) regarding a 18 year old female patient (student). On 04-JUL-2014 at 8:31 am, the patient might have been immunized with a dose of (Merck) VARIVAX lot number J009165, expiration date 24-JUL-2015, in the right arm (dose number, route and dose were not reported) which was not stored at the appropriate temperature (not further specified). Concomitant medications were not specified. The outcome of the event was reported as unknown. This is one of several reports received from the same source. Additional information is not expected because follow up has been obtained.
C/O feeling short of breath & flushed at times. Unsure if he went to his primary doctor for a follow up. He was found deceased at home by his daughter